Let’s start up with the current stock price of Legend Biotech Corporation (LEGN), which is $51.92 to be very precise. The Stock rose vividly during the last session to $57.525 after opening rate of $57.06 while the lowest price it went was recorded $49.11 before closing at $56.91.Recently in News on September 22, 2021, Legend Biotech to Host R&D Day on October 18, 2021. Legend Biotech Corporation (NASDAQ: LEGN), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, will host its first Research & Development Day on Monday, October 18, commencing at 10:00 a.m. (Eastern Time), at Andaz 5th Avenue in New York. You can read further details here
Legend Biotech Corporation had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $58.00 on 10/12/21, with the lowest value was $23.41 for the same time period, recorded on 03/04/21.
Legend Biotech Corporation (LEGN) full year performance was 75.29%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Legend Biotech Corporation shares are logging -10.48% during the 52-week period from high price, and 121.79% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $23.41 and $58.00.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 821392 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Legend Biotech Corporation (LEGN) recorded performance in the market was 84.37%, having the revenues showcasing 31.84% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 7.64B, as it employees total of 882 workers.
Legend Biotech Corporation (LEGN) in the eye of market guru’s
During the last month, 0 analysts gave the Legend Biotech Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 42.09, with a change in the price was noted +12.07. In a similar fashion, Legend Biotech Corporation posted a movement of +30.29% for the period of last 100 days, recording 426,215 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for LEGN is recording 0.06 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.06.
Legend Biotech Corporation (LEGN): Stocks Technical analysis and Trends
Raw Stochastic average of Legend Biotech Corporation in the period of last 50 days is set at 73.73%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 67.01%. In the last 20 days, the company’s Stochastic %K was 85.94% and its Stochastic %D was recorded 89.47%.
If we look into the earlier routines of Legend Biotech Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 84.37%. Additionally, trading for the stock in the period of the last six months notably improved by 101.24%, alongside a boost of 75.29% for the period of the last 12 months. The shares increased approximately by -1.07% in the 7-day charts and went down by 37.35% in the period of the last 30 days. Common stock shares were driven by 31.84% during last recorded quarter.